Carbonic anhydrases (CAs, EC 4.2.1.1) are wide-spread zinc enzymes, present in archaeo- and eubacteria, algae, green plants and animals. Within these organisms CAs are encoded by three distinct, evolutionarily unrelated gene families: the α-CA, the β-CA and the γ-CA families, respectively. These enzymes are very efficient catalysts for the reversible hydration of CO2 to bicarbonate;…
Expert Opinion on Therapeutic Patents Template
Write in a clean editor, then format for Expert Opinion on Therapeutic Patents in one click — DocuGuru applies the official Taylor & Francis template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Expert Opinion on Therapeutic Patents format
Expert Opinion on Therapeutic Patents is a peer-reviewed journal published by Taylor & Francis, covering Intellectual Property and Patents, Diverse Scientific and Economic Studies, Legal Cases and Commentary.
| Publisher | Taylor & Francis |
|---|---|
| Reference style | Author–year (Chicago, T&F) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Expert Opinion on Therapeutic Patents 12 (3): 45–58.
Formats any DOI in Expert Opinion on Therapeutic Patents style. No sign-up. |
| Publishes research in | Intellectual Property and Patents Diverse Scientific and Economic Studies Legal Cases and Commentary Receptor Mechanisms and Signaling Monoclonal and Polyclonal Antibodies Research |
| ISSN | 1354-3776 |
| Citation impact (2-yr) | 5.13 |
| h-index | 103 |
| i10-index | 1,546 |
| Total citations | 69,809 |
| Top institutions publishing here | Weatherford College |
| Journal website | informahealthcare.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Expert Opinion on Therapeutic Patents per year
Citation impact of Expert Opinion on Therapeutic Patents by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Expert Opinion on Therapeutic Patents
INTRODUCTION: Schiff bases are synthetically accessible and structurally diverse compounds, typically obtained by facile condensation between an aldehyde, or a ketone with primary amines. Schiff bases contain an azomethine (-C = N-) linkage that stitches together two or more biologically active aromatic/heterocyclic scaffolds to form various molecular hybrids with interesting biological properties. Schiff bases are…
Introduction: Solid lipid nanoparticles (SLNs) are solid core lipid nanocarriers, which can hold both hydrophilic and hydrophobic drugs. They can be made up of biocompatible ingredients and therefore are one of the preferred choices for drug delivery. Surface modifications of SLNs may further provide unique features to them like mucoadhesiveness or targeting capability.Areas covered: In…
INTRODUCTION: Glaucoma is one of the major causes of blindness, affecting together with age-related macular degeneration > 70 million people worldwide. One of the therapeutic options for its management is based on the inhibition of the metalloenyme carbonic anhydrase (CA, EC 4.2.1.1). CA inhibitors (CAIs) diminish intraocular pressure (IOP) by reducing the rate of bicarbonate…